The reiteration of a Buy rating and a maintained price target by a reputable analyst firm like HC Wainwright & Co. typically signals continued confidence in the company's prospects. This endorsement can positively influence investor sentiment and potentially lead to a short-term increase in stock price, especially if the market perceives the analysis as a strong vote of confidence in Aquestive Therapeutics' future performance.